Objective
The MAP-kinase pathway is a major pathway in relaying signals from the plasma membrane into the nucleus. Its comprehensive understanding is needed for rational anti-cancer therapies.
SIMAP will develop a comprehensive and robust simulation model of the pathway; populating it with kinetic parameters extracted from the literature and experimental work; simulating various types of inputs into the model; creating qualitative predictions and verifying them with independent experimentations. The model will integrate and analyse data from various types of resources vertically ranging from single molecule information, pathway modelling, up to clinical data and patient's response. SIMAP pioneers the integration of clinical phenotype into this improved biochemical model. Such multi-scale modelling has never been done in the field of Systems Biology and is a step forward.
Combining generic mechanistic modelling of the biochemical behaviour, accompanied by new generic mining techniques and clinical data integration, will create a multidisciplinary platform prototype suitable for modelling of other cancer related pathways.
Our approach will enable hypothesis-driven research aimed at the establishment of system level computational platforms available for various pharmaceutical applications. The concepts and methods we will develop will lead to the design of new therapeutic drugs, decrease the attrition rate of new drugs and make it possible to select patients on the basis of individual parameters of disease. Modelling-driven predictions regarding the impact of drug combinations will permit us to dramatically improve the design of pre-clinical and clinical trials, enhance patient response and limit adverse effects. Eventually this will optimise Public Health resources leading to significant pharmacoeconomic benefit.
The project is lead by a drug and diagnostic discovery SME and an interdisciplinary industrial and academic leading teams of investigators.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences public health
- medical and health sciences clinical medicine oncology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
69512 TEL-AVIV
Israel
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.